Chemours Company (the) · NYSE:CC

Chemours Company (the) — Q3 2025 Earnings Presentation

26 slides from Chemours Company (the)'s earnings presentation, Nov 7, 2025

  1. Slide 1: The Chemours Company Q3 2025 Earnings Presentation

    THE CHEMOURS COMPANY Q3 2025 EARNINGS PRESENTATION November 7, 2025

  2. Slide 2: Safe Harbor Statement and Other Matters

    Safe Harbor Statement and Other Matters This presentation contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. Forward-looking statements provide current exp

  3. Slide 3: Third Quarter 2025 Highlights

    Third Quarter 2025 Highlights Generated $1.5B in Net Sales and $195M in Adjusted EBITDA Achieved 80% YoY Net Sales growth for Opteon Refrigerants in TSS, reflecting continued strong adoption Announced the successful qualification of Chemours’ two-phase immersion cooling fluid by Samsung Electronics

  4. Slide 4: Third Quarter 2025 Financial Summary

    Third Quarter 2025 Financial Summary ($ in millions unless otherwise noted; excludes per share amounts) 3Q25 3Q24 5 Y-o-Y ∆ 2Q25 Q-o-Q ∆ Net Sales $1,495 $1,508 ($13) $1,615 ($120) Net Income / (Loss) 1 $60 ($32) $92 ($381) $441 Adj. Net Income 2 $30 $61 ($31) $87 ($57) EPS 3 $0.40 ($0.22) $0.62 ($2

  5. Slide 5: Adjusted EBITDA Bridge: 3Q25 versus 3Q24

    Adjusted EBITDA Bridge: 3Q25 versus 3Q24 ($ in millions) $18 $7 ($47) $15 $202 $195 5 3Q24 Price Volume Cost/Other Currency 3Q25 Price Impacts: $7 million due to higher pricing in TSS primarily driven by stronger Opteon Refrigerant blends aftermarket demand and strong pricing in APM, in connection w

  6. Slide 6: Quarterly Segment Summary

    Quarterly Segment Summary ($ in millions unless otherwise noted) Net Sales 5 TSS TT APM $436 $468 $560 $690 $672 $612 $343 $354 $311 3Q23 3Q24 3Q25 3Q23 3Q24 3Q25 3Q23 3Q24 3Q25 Adjusted EBITDA and Margin 5 (%) TSS TT APM $25 $14 $162 $139 $194 $69 $78 $68 $38 3Q23 3Q24 3Q25 3Q23 3Q24 3Q25 3Q23 3Q24

  7. Slide 7: Liquidity Position as of September 30, 2025

    Liquidity Position as of September 30, 2025 ($ in millions unless otherwise noted) Total Liquidity 9 $1.6B Gross Debt $4.2B Net Debt 10 $3.6B TTM Net Leverage 11 4.6x $665 $52 Restricted $553 ($41) ($13) $20 $51 Restricted $146 $502 $613 Unrestricted Unrestricted 2Q25 Cash Balance 6 Operating Cash F

  8. Slide 8: Strategic Progress

    STRATEGIC PROGRESS PATHWAY TO THRIVE

  9. Slide 9: Our Strategy

    Our Strategy PATHWAY TO THRIVE Operational Enabling Portfolio Strengthening Excellence Growth Management the Long-Term ❑Manufacturing excellence as ❑Investing smartly in selected ❑Holistic portfolio analysis ❑Measurable progress on a basis for success growth projects focused on distinct value resolv

  10. Slide 10: Progress Achieved to Date

    Progress Achieved to Date PATHWAY TO THRIVE Operational Enabling Portfolio Strengthening Excellence Growth Management the Long-Term ✓ On track to deliver ~$125M of ✓ Continued double-digit growth with ✓ Strategic agreement with SRF ✓ Agreed to a proposed Judicial gross cost savings within 80% YoY qu

  11. Slide 11: 2024 Sustainability Report Highlights

    2024 Sustainability Report Highlights Reduced total process FOC emissions 76%*—on our way to a 99% or more reduction by 2030 Achieved 52%* reduction of operational GHG emissions—on track to meet our 60% reduction by 2030 Accomplished the 2030 Sustainable Offerings goal 6 years early; 50% of revenue

  12. Slide 12: Q4 and Full Year

    SB O4 AND Gao}! FULL YEAR 1°,

  13. Slide 13: Fourth Quarter 2025 Guidance

    Fourth Quarter 2025 Guidance Sequential Business Outlook:  Consolidated o Net Sales: Expected to decrease 10-15% sequentially Full Year 2025 Outlook o Adjusted EBITDA: Expected to range between $130 million and $160 million o Corporate Expenses as an offset to Adjusted EBITDA: Expected to range bet

  14. Slide 14: Appendix

    APPENDIX 14

  15. Slide 15: TSS Segment Net Sales and Adjusted EBITDA

    TSS Segment Net Sales and Adjusted EBITDA (Unaudited)5 ($ in millions) ($ in millions) % of total Net Sales $560 $468 FP&O $35 17% FP&O $57 Freon 25% Refrigerants Freon 17% Refrigerants Q3 24 % total Q3 25 % total 31% refrigerants: refrigerants: Freon = 42% Freon = 20% Opteon = 58% Opteon = 80% Opte

  16. Slide 16: TT Segment Net Sales and Adjusted EBITDA

    TT Segment Net Sales and Adjusted EBITDA (Unaudited)5 ($ in millions) ($ in millions) $672 $612 ($43) ($17) $78 $25 3Q24 Price/Currency Volume 3Q25 3Q24 Price/Currency Volume Cost/Other 3Q25 Net Sales: The year-over-year decrease was primarily driven by an 8% decrease in price globally, partially of

  17. Slide 17: APM Segment Net Sales and Adjusted EBITDA

    APM Segment Net Sales and Adjusted EBITDA (Unaudited)5 ($ in millions) ($ in millions) % of total Net Sales $354 $311 Performance $11 Solutions ($54) Performance 40% Solutions 39% Advanced Advanced Materials Materials 60% 61% $38 $14 3Q24 Price/Currency Volume 3Q25 3Q24 Price/Currency Volume Cost/Ot

  18. Slide 18: Segment Net Sales

    Segment Net Sales (Unaudited)5 18 Chemours - Internal Use Only

  19. Slide 19: Segment Net Sales by Region

    Segment Net Sales by Region (Unaudited)5 2023 2024 2025 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Net sales by geographic region North America: Thermal & Specialized Solutions $ 292 $ 319 $ 258 $ 207 $ 271 $ 308 $ 256 $ 194 $ 233 $ 336 $ 316 Titanium Technologies 262 277 273 242 246 274 270 236 267 282 252 A

  20. Slide 20: Actual and Projected Disruption & Investment Costs

    Actual and Projected Disruption & Investment Costs (Unaudited) 2024 2025 ($, millions) Q1 - Act Q2 - Act Q3 - Act Q4 - Act Total Q1 - Act Q2 - Act Q3 - Act Q4 - Guide Total Disruption Costs Thermal & Specialized Solutions (TSS) Winter Storm $ - $ - $ - $ - $ - $ 5 $ - $ - $ - $ 5 Titanium Technologi

  21. Slide 21: Segment Net Sales and Adjusted EBITDA

    Segment Net Sales and Adjusted EBITDA (Unaudited)5 2023 2024 2025 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Segment Net Sales Thermal & Specialized Solutions $ 494 $ 533 $ 444 $ 380 $ 454 $ 519 $ 468 $ 390 $ 466 $ 597 $ 560 Titanium Technologies 632 707 690 651 591 677 672 632 597 657 612 Advanced Performanc

  22. Slide 22: GAAP Net Income to Adjusted Net Income and EBITDA

    GAAP Net Income (Loss) Attributable to Chemours to Adjusted Net Income and Adjusted EBITDA Reconciliation (Unaudited) GAAP Net Leverage Ratio to Non-GAAP Net Leverage Ratio5 (Page 1/2) ($ in millions except per share amounts) Three Months Ended Three Months Ended Twelve Months Ended September 30, Ju

  23. Slide 23: GAAP Net Income to Adjusted Net Income and EBITDA

    GAAP Net Income (Loss) Attributable to Chemours to Adjusted Net Income and Adjusted EBITDA Reconciliation (Unaudited) GAAP Net Leverage Ratio to Non-GAAP Net Leverage Ratio5 (Page 2/2) ($ in millions except per share amounts) Three Months Ended Three Months Ended Twelve Months Ended September 30, Ju

  24. Slide 24: GAAP Cash Flow to Free Cash Flow

    GAAP Cash Flow Provided by Operating Activities to Free Cash Flows and Free Cash Flow Conversion Reconciliation ($ in millions) Three Months Ended Nine Months Ended September 30, June 30, September 30, 2025 2024 2025 2025 2024 Cash flows provided by (used for) operating activities $ 146 $ 139 $ 93 $

  25. Slide 25: 2025 Estimated GAAP Net Income to Adjusted EBITDA

    2025 Estimated GAAP Net Income Attributable to Chemours to Estimated Adjusted Net Income, Estimated Adjusted EBITDA(*) (In millions except per share amounts) (Estimated) Year Ending December 31, 2025 Low High Net loss attributable to Chemours $ (335) $ (318) Restructuring, transaction, and other cos

  26. Slide 26: 2025 Chemours. All Rights Reserved

    ® 2025 CHEMOURS. ALL RIGHTS RESERVED​

Chemours Company (The) — Q3 2025 Earnings Presentation on 6ix